Primary hyperparathyroidism and osteoporosis in 2004.
In patients with primary hyperparathyroidism, a definite diagnosis is the first step in the management strategy and relies on appropriately selected and carefully interpreted laboratory tests. Parathyroid hormone assays are being increasingly performed as part of the routine evaluation of osteoporosis. In this setting, laboratory tests are often consistent with primary hyperparathyroidism but should be interpreted with caution. Bone mineral density measurements are useful for assessing the impact of primary hyperparathyroidism. The recommended bone mineral density cutoffs for selecting patients requiring parathyroidectomy were lowered in 2003, and the number of surgically treated patients has increased as a result. Parathyroidectomy remains the treatment of choice given the low mortality associated with this procedure and the absence of pharmacological alternatives suitable for long-term use.
Cormier
Catherine
C
Rheumatology department A (Prof. A. Kahan), Cochin Teaching Hospital, 27, rue du Faubourg Saint-Jacques 75014, Paris, France. catherine.cormier@cch.ap-hop-paris.fr
Souberbielle
Jean-Claude
JC
Kahan
André
A
D015519:Bone Density; D001851:Bone Diseases, Metabolic / Q000209:etiology; D004872:Ergocalciferols / Q000097:blood; D006801:Humans; D006934:Hypercalcemia / Q000209:etiology; D006961:Hyperparathyroidism / Q000150:complications* / Q000175:diagnosis* / Q000601:surgery; D010024:Osteoporosis / Q000209:etiology*; D016105:Parathyroidectomy; D011184:Postoperative Period
D004872:Ergocalciferols